Profile | GDS4284 / 234975_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1077.58 | 75 |
GSM687648 | Patient 402 control | 1166.96 | 76 |
GSM687653 | Patient 403 control | 1870.04 | 83 |
GSM687658 | Patient 404 control | 930.473 | 73 |
GSM687663 | Patient 411 control | 1536.69 | 80 |
GSM687668 | Patient 422 control | 1787.52 | 82 |
GSM687673 | Patient 424 control | 2008.48 | 84 |
GSM687678 | Patient 425 control | 1592.48 | 80 |
GSM687683 | Patient 427 control | 1023.02 | 74 |
GSM687688 | Patient 428 control | 874.881 | 72 |
GSM687695 | Patient 441 control | 1323.34 | 79 |
GSM687699 | Patient 443 control | 1165.87 | 76 |
GSM687704 | Patient 444 control | 1195.13 | 77 |
GSM687707 | Patient 448 control | 2137.79 | 85 |
GSM687712 | Patient 449 control | 873.822 | 72 |
GSM687719 | Patient 450 control | 1270.12 | 77 |
GSM687724 | Patient 451 control | 1552.84 | 81 |
GSM687728 | Patient 452 control | 947.468 | 74 |
GSM687646 | Patient 401 treated 24h | 1110.79 | 75 |
GSM687649 | Patient 402 treated 24h | 1330.28 | 78 |
GSM687665 | Patient 411 treated 24h | 1302.03 | 78 |
GSM687651 | Patient 402 treated 4 weeks | 1343.6 | 78 |
GSM687667 | Patient 411 treated 4 weeks | 1615.48 | 81 |
GSM687670 | Patient 422 treated 24h | 1626.26 | 81 |
GSM687671 | Patient 422 treated 4 weeks | 2080.47 | 84 |
GSM687654 | Patient 403 treated 24h | 1770.48 | 82 |
GSM687675 | Patient 424 treated 24h | 1814.85 | 83 |
GSM687685 | Patient 427 treated 24h | 958.11 | 73 |
GSM687656 | Patient 403 treated 4 weeks | 2172.68 | 85 |
GSM687677 | Patient 424 treated 4 weeks | 1451.52 | 79 |
GSM687687 | Patient 427 treated 4 weeks | 1563.97 | 80 |
GSM687692 | Patient 428 treated 4h | 1096.5 | 75 |
GSM687716 | Patient 449 treated 4h | 652.755 | 68 |
GSM687722 | Patient 450 treated 4h | 777.374 | 70 |
GSM687680 | Patient 425 treated 24h | 1371.14 | 78 |
GSM687690 | Patient 428 treated 24h | 884.424 | 73 |
GSM687700 | Patient 443 treated 24h | 940.535 | 72 |
GSM687705 | Patient 444 treated 24h | 816.246 | 71 |
GSM687714 | Patient 449 treated 24h | 908.157 | 73 |
GSM687721 | Patient 450 treated 24h | 1108.3 | 76 |
GSM687682 | Patient 425 treated 4 weeks | 1029.52 | 74 |
GSM687694 | Patient 428 treated 4 weeks | 1180.09 | 76 |
GSM687702 | Patient 443 treated 4 weeks | 1027.83 | 74 |
GSM687718 | Patient 449 treated 4 weeks | 649.637 | 68 |
GSM687723 | Patient 450 treated 4 weeks | 1176.82 | 76 |
GSM687661 | Patient 404 treated 4h | 866.763 | 72 |
GSM687710 | Patient 448 treated 4h | 2485.18 | 87 |
GSM687726 | Patient 451 treated 4h | 1940.73 | 84 |
GSM687730 | Patient 452 treated 4h | 275.048 | 39 |
GSM687660 | Patient 404 treated 24h | 536.819 | 65 |
GSM687697 | Patient 441 treated 24h | 1381.25 | 79 |
GSM687709 | Patient 448 treated 24h | 2139.78 | 85 |
GSM687725 | Patient 451 treated 24h | 2215.39 | 85 |
GSM687729 | Patient 452 treated 24h | 839.174 | 73 |
GSM687727 | Patient 451 treated 4 weeks | 2245.2 | 85 |
GSM687731 | Patient 452 treated 4 weeks | 1295.57 | 78 |